Skip to main content

. 1967 Sep;21(3):512–518. doi: 10.1038/bjc.1967.60

Thyroid activity in relation to prognosis in mammary cancer.

K Sicher, J A Waterhouse

PMCID: PMC2008033 PMID: 4167989

512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CAPPELLI L., MARGOTTINI M. THYROID FUNCTION IN CANCER PATIENTS. Acta Unio Int Contra Cancrum. 1964;20:1493–1496. [PubMed] [Google Scholar]
EDELSTYN G. A., LYONS A. R., WELBOURN R. B. Thyroid function in patients with mammary cancer. Lancet. 1958 Mar 29;1(7022):670–671. doi: 10.1016/s0140-6736(58)91088-2. [DOI] [PubMed] [Google Scholar]
HUMPHREY L. J., SWERDLOW M. THE RELATIONSHIP OF BREAST DISEASE TO THYROID DISEASE. Cancer. 1964 Sep;17:1170–1173. doi: 10.1002/1097-0142(196409)17:9<1170::aid-cncr2820170912>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
LYONS A. R., EDELSTYN G. A. THYROID HORMONE AS A PROPHYLACTIC AGENT FOLLOWING RADICAL TREATMENT OF BREAST CANCER. Br J Cancer. 1965 Mar;19:116–121. doi: 10.1038/bjc.1965.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
REEVE T. S., RUNDLE F. F., HALES I. B., MYHILL J., CROYDON M. Thyroid function in the presence of breast cancer. Lancet. 1961 Mar 25;1(7178):632–633. doi: 10.1016/s0140-6736(61)91653-1. [DOI] [PubMed] [Google Scholar]
STOLL B. A. A clinical trial of tri-iodothyronine as a hormone potentiator in advanced breast cancer. Br J Cancer. 1962 Sep;16:436–440. doi: 10.1038/bjc.1962.48. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES